The significance of Doppler flow and anamnesis in the diagnosis of fallopian tube cancer

By following Doppler flow of the small pelvis with laboratory parameters and anamnesis data, we obtained more precise diagnostic possibilities for timely discovering of malignant processes in adnexal region and fallopian tube. By following patients who had come for routine check ups, prompted by a positive family history for malignant processes, resistant indexes of blood vessels in the adnexal region and vascularisation pattern were determined. Out of 78 women observed in the postmenopausal period with diagnosed adnexal masses, we found two cases of fallopian tube cancer. Resistance indexes ranged between 0.20 and 0.30 during a one-month period. Hystopathological analysis pointed to fallopian tube cancer. Besides Doppler flow, only patient history of amber extract use was significant. By CA 125 marker analysis, we found an increased value but not signifiant enough. Both patients had a positive family history according to the female hereditary line.

Fallopian tube cancer; Doppler flow; Amber extract

[1] Andersen W.A., Young D.E., Peters W.A., Smith E.B. et al.: "Platinum- based combination chemotherapz for malignant mixed mesodermal tumors of the ovary". Gynecol. Oncol., 1989, 32, 319.

[2] Arrastia C.D., Fruchter R.G., Clark M., Maiman M., Remy J.C., Macasaet M. et al.: "Uterine carcinosarcomas: incidence and trends in management and survival". Gynecol. Oncol., 1997, 65, 158.

[3] Cenacchi G., Pasquinelli G., Montanaro L., Cerasoli S., Vici M., Bisceglia M. et al.: "Primary endocervical extraosseous Ewing's sarcoma/PNET". Int. J. Gynecol. Pathol., 1998, 17, 83.

[4] Clement P.B., Zubovits J.T., Young R.H., Scully R.E.: "Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus". Int. J. Gynecol. Pathol., 1998, 17, 211.

[5] Emerich J., Konefka T., Dudziak M.: "Malignant non-epithelial neoplasms of the uterine body-clinical analysis". Ginekol. Pol., 1997, 68, 610

[6] Feroze M.,A ravindan K.P.,T homas M.: "Mullerian adenosarcoma of the uterine cervix". Indian J. Cancer, 1997, 34, 68.

[7] Forney J.P., Buschbaum H.J.: "Classifying, staging and treating uterine sarcomas". Contemporary Obstet. Gynecol., 1981, 18, 47.

[8] Fotiou S., Hatjieleeftheriou G., Kyrousis G., Kokka F., Apostolikas N.: "Long-term tamoxifen treatment: a possible aetiological factor in the development of uterine carcinosarcoma: two casereports and review of the literature". Anticancer Res., 2000, 20, 2015.

[9] Harlow B.L., Weiss N.S., Lofton S.: "The epidemiology of sarcomas of the uterus". J. Natl Cancer Inst., 1986, 76, 399.

[10] Hays D.M., Shimada H., Raney R.B. i saradnici: "Clinical stagmg and treatment results in rhabdomyosarcoma of the female genital tract among children and adolescents". Cancer, 1988, 61, 1893.

[11] Kohler U., Hom LC., Marzotko E., Bilek K.: "Primary dedifferentiated leiomyosarcoma of the fallopian tube". Zentralbl Gynakol., 1997, 119, 237.